Literature DB >> 33049104

Glucagon in type 1 diabetes patients receiving SGLT2 inhibitors: A Friend or Foe?

Tomoyasu Fukui1, Makoto Ohara1, Sho-Ichi Yamagishi1.   

Abstract

Entities:  

Keywords:  LDL cholesterol; glucagon; type 1 diabetes

Mesh：

Substances：

Year:  2020        PMID： 33049104     DOI： 10.1002/dmrr.3415

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN： 1520-7552            Impact factor:   4.876


× No keyword cloud information.
  1 in total

1.  SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants With Type 1 Diabetes.

Authors:  Schafer C Boeder; Justin M Gregory; Erin R Giovannetti; Jeremy H Pettus
Journal:  Diabetes       Date:  2022-03-01       Impact factor: 9.461
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.